Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H27ClF5NO |
Molecular Weight | 523.965 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1(CCN(CCCC(C2=CC=C(F)C=C2)C3=CC=C(F)C=C3)CC1)C4=CC=C(Cl)C(=C4)C(F)(F)F
InChI
InChIKey=MDLAAYDRRZXJIF-UHFFFAOYSA-N
InChI=1S/C28H27ClF5NO/c29-26-12-7-21(18-25(26)28(32,33)34)27(36)13-16-35(17-14-27)15-1-2-24(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24,36H,1-2,13-17H2
Molecular Formula | C28H27ClF5NO |
Molecular Weight | 523.965 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6408670
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6408670
Penfluridol is a highly potent; first generation diphenylbutylpiperidine antipsychotic was developed by Janssen Pharmaceutica in 1968 and is used to treat schizophrenial and similar psychotic disorders. It is, however, like most typical antipsychotics, being increasingly replaced by the atypical antipsychotics. This drug is long-acting dopamine receptor blocker.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2579392
Curator's Comment: # Janssen Pharmaceutica, Beerse, Belgium
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096905 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6408670 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Pharmacological studies of antipsychotic drug, penfluridol. 2. General pharmacological properties]. | 1976 Jul |
|
Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia. | 1988 Oct-Dec |
|
An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1. | 2002 Dec 20 |
|
Differential inhibition of T-type calcium channels by neuroleptics. | 2002 Jan 15 |
|
LC-MS-MS analysis of the neuroleptics clozapine, flupentixol, haloperidol, penfluridol, thioridazine, and zuclopenthixol in hair obtained from psychiatric patients. | 2002 Jul-Aug |
|
Brief psychotic disorder associated with Sturge-Weber syndrome. | 2005 Jun |
|
Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. | 2005 Mar |
|
Penfluridol for schizophrenia. | 2006 Apr 19 |
|
Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. | 2006 Sep |
|
Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches. | 2007 |
|
Antipsychotics and risk of venous thromboembolism: A population-based case-control study. | 2009 Aug 9 |
|
The position of mefloquine as a 21st century malaria chemoprophylaxis. | 2010 Dec 9 |
|
Research on antipsychotics in India. | 2010 Jan |
|
An overview of Indian research in schizophrenia. | 2010 Jan |
Patents
Sample Use Guides
Initial: 20-60 mg/week. Severe/resistant: ≤250 mg/week.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24528079
Curator's Comment: Growth inhibition of mouse cancer cell lines by penfluridol was determined using the 3- (4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Penfluridol inhibited the proliferation of B16 melanoma (B16/ F10), LL/2 lung carcinoma (LL/2), CT26 colon carcinoma (CT26) and 4T1 breast cancer (4T1) cells in vitro.
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:51:18 GMT 2023
by
admin
on
Fri Dec 15 16:51:18 GMT 2023
|
Record UNII |
25TLU22Q8H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66883
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
||
|
WHO-ATC |
N05AG03
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
||
|
WHO-VATC |
QN05AG03
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C90843
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL47050
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
D010395
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
2080
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
759179
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
SUB09664MIG
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
DTXSID5049021
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
2919
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
100000082499
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
248-074-5
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
7974
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
Penfluridol
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
DB13791
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
25TLU22Q8H
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
m8466
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
33630
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY | |||
|
26864-56-2
Created by
admin on Fri Dec 15 16:51:18 GMT 2023 , Edited by admin on Fri Dec 15 16:51:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |